A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma.Emily K. Slotkin, William D. Tap, Michael V. Ortiz et al.|Journal of Clinical Oncology|2022Cited by 14